SINGAPORE, Oct. 11, 2024 /PRNewswire/ -- Helicap Group is proud to announce that GMO Payment Gateway, Inc. (TSE Prime Market Securities Code: 3769, President & CEO: Issei Ainoura), a leading provider of payment and financial-related services under the GMO Internet Group, has made a USD 3 million investment in Helicap's flagship credit fund managed by Helicap Investments Pte Ltd, a regulated subsidiary of the Helicap Group. The investment was executed through GMO-PG's Singapore-based subsidiary, GMO-Z.COM PAYMENT GATEWAY PTE. LTD.
A Partnership to Bridge Southeast Asia's Funding Gap
In the first half of 2024, FinTech startups in Southeast Asia secured a notable USD 899.3 million in funding, highlighting the region's enduring appeal amidst global economic headwinds.*1 This demonstrates the sector's resilience, fueled by Southeast Asia's strong demand for innovative financial solutions as traditional services evolve to meet modern needs. Helicap, together with its regulated subsidiaries, aims to address the region's USD 500 billion funding gap.*2 This period marks the rise of key players leveraging technology to build scalable, inclusive financial services, solidifying Southeast Asia as a thriving FinTech hub. This latest investment from GMO-PG underscores their commitment to supporting innovative FinTech solutions and aligning with Helicap's vision of driving financial inclusion in underserved markets. Through this partnership, Helicap will continue to empower FinTech companies that are transforming the financial landscape of Southeast Asia, while opening doors to new business opportunities in markets that remain untapped.
*1 Tracxn Technologies Limited「FinTech - Southeast Asia Semi Annual Funding Report - H1 2024ã€
*2 As of 2017
About Helicap Pte Ltd 'Helicap'
Helicap is a Singapore-based FinTech firm facilitating private debt opportunities in Southeast Asia. As a group, the goal is to fill a USD 500 billion financing gap that banks are unable to serve and deploy capital to 300 million underbanked through 1,000 originators in the region. Helicap's equity backers include Malaysia's leading independent investment bank, Kenanga Investment Bank Berhad ("Kenanga Group"), Japanese financial services firm Credit Saison, Temasek-backed alternative investments firm Tikehau Capital, integrated Asian financial house PhillipCapital, as well as top VC firms East Ventures, Access Ventures, Voveo Capital, and leading Singapore property group SoilbuildGroup Holdings.
Over the last 6 years, Helicap has raised more than USD 15 million in paid-up capital, and via its regulated subsidiaries, has deployed almost USD 400 million worth of capital with its in-house data analytics expertise. By leveraging this advanced data-processing capability, they have indirectly served more than 5 million MSMEs and individuals. Helicap's collaboration with Temasek Trust on Southeast Asia's first Financial Inclusion Report exemplifies the commitment to building a visible, impactful, and integrated ecosystem that prioritizes sustainable and ethical practices.
For more information, visit www.helicap.com.
About GMO Payment Gateway, Inc.
GMO Payment Gateway, Inc. provides payment-related services that support the customer's online and cashless migration and digital transformation (DX). Annual transaction value exceeds 17 trillion yen and its online comprehensive payment services have been adopted by over 150,000 merchants such as EC operators and public institutions of NHK and National Tax Agency, etc.
As the leading company in the payment industry, GMO contributes to the advancement and realization of a sustainable society by driving social innovations using payment and financial technology through its services, such as online comprehensive payment service, payment services in the offline market, Buy Now Pay Later (BNPL), BaaS Support services to financial institutions and enterprises and strategic investment and lending to overseas leading-edge FinTech companies. (As of end-June 2024, consolidated figures)
For more information, visit: www.gmo-pg.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
GMO Payment Gateway, Inc. Invests USD 3 Million in Helicap's Flagship Credit Fund to Drive Growth of FinTech in Southeast Asia
SINGAPORE, Oct. 11, 2024 /PRNewswire/ -- Health Management International Pte Ltd ("HMI Medical), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, announces a new partnership with its fifth specialist group by acquiring a majority stake in Advanced Urology Associates ("Advanced Urology"), the largest private urology specialist group in Singapore. This partnership will strengthen HMI Medical's specialist service offerings and will be added to its' existing portfolio of specialist groups: Eagle Eye Centre, Eagle Aesthetics and Surgery, Harley Street Heart & Vascular Centre, and The Orthopaedic Practice and Surgery.
To support patients in Singapore in managing their health more proactively and reducing friction in their healthcare journeys, HMI Medical has been growing organically and through strategic mergers and acquisitions. The latest addition of Advanced Urology aligns with HMI Medical's growth strategy in Singapore, which focuses on providing quality and patient-centred healthcare services outside of hospitals that are convenient and delivers value. Urology is a prime example of a specialist discipline where majority of procedures can be carried out safely in an out of hospital setting, via minimally invasive procedures and new technologies.
"We are excited to welcome Advanced Urology to be part of our growing portfolio of specialist services as we seek to enhance urology care against the backdrop of a fast-aging population. With an aligned vision and the collective track record of Dr James Tan, Dr Gerald Tan, Dr Lewis Liew and their team of highly skilled urology specialists, we can continue to spark change for the future of healthcare together", said Chin Wei Jia, Group CEO at HMI Medical.
Prostate cancer is the most common cancer for men[1] and urinary tract infections are among the top 10 causes of mortality in Singapore[2]. Through this strategic partnership with HMI Medical, Advanced Urology seeks to enhance access to specialist care services covering all sub specialities in urology to patients in Singapore and the region. With the support of HMI Medical's extensive patient care network, Advanced Urology aims to expand its footprint locally and regionally by scaling up their community outreach, doctor recruitment efforts and establishment of new clinics and health facilities.
"We are delighted to have found a purpose-driven, like-minded partner in HMI Medical. With a common commitment to take a patient-centric approach to healthcare, we believe our collective expertise will make a positive impact in our communities as we grow together," said Dr James Tan, Chairman of Advanced Urology. "We are optimistic about the new opportunities to create synergies among HMI Medical's existing health services across the entire continuum of care, to serve our patients better", he added.
Advancing out-of-hospital care by Integrating Specialist Services with Ambulatory Care Centres
Ambulatory surgery, also known as outpatient surgery, has gained global significance in recent years due to the clinical and technological advancements which allow patients to undergo minimally invasive procedures and return home within a day. According to global reports, studies have shown that ambulatory care settings can provide advantages for patients, such as shorter average visit length—25% shorter for ambulatory-care services than comparable hospital outpatient visits[3] as well as reduced risk of hospital infections, faster recovery time, while decreasing health expenses. In Singapore, the annual number of surgeries and procedures performed at day surgery centres have risen from 509,000 in 2019 to 565,000 in 2022[4]. With HMI Medical's day surgery operating theatres and recovery rooms, patients with urology related health needs can undergo minimally invasive surgical procedures and complete their health journey under one roof.
Tardis Capital advised Advanced Urology in this transaction.
About HMI Medical
Headquartered in Singapore, HMI Medical (previously known as HMI Group) is a growing regional private healthcare provider with over 25 years of experience across Singapore, Malaysia and Indonesia. The Group serves over 3 million patients per year through a full suite of digital and physical services including its leading tertiary hospitals in Malaysia. In Singapore, the Group operates 45 primary care and health screening centres, 21 specialist centres, an 11-storey ambulatory care centre, and manages a panel of 1,500 primary and specialist clinics through its medical benefits administrative network. The Group also runs a dedicated training centre - a social enterprise focused on continuous education and community engagement. In Malaysia, it owns 2 leading Medisave-approved tertiary hospitals in Malaysia and an ambulatory care centre, namely Mahkota Medical Centre in Malacca, and Regency Specialist Hospital. The Group recently launched Regency Medical Care Centre, its first ambulatory care centre located in The Mall, Mid Valley SouthKey, 15 minutes from the Singapore Woodlands checkpoint. For more information, please visit: https://www.hmimedical.com/
About Advanced Urology Associates
Founded in 2018, Advanced Urology is the largest group of urology specialists in private practice in Singapore working cohesively to design a comprehensive evidence-based treatment approach for solving complex and challenging urology conditions. Today, Advanced Urology operates 6 centres located in the major private hospitals island wide together with a team of 7 resident urologists, offering a comprehensive range of urology services for Kidney, Bladder, Prostate, Robotics Surgery, Men's and Women's health. Advanced Urology Associates are also specially trained in urological cancer surgery, robotic surgery, complex stone surgery and transplant surgery. Other than complex cancer and robotic surgeries conducted in a hospital setting, they also have dedicated facilities and latest technologies to carry out surgical procedures that are MediSave claimable.
For more information, please visit: https://urology.com.sg/
[1] https://www.singaporecancersociety.org.sg/learn-about-cancer/cancer-basics/common-types-of-cancer-in-singapore.html
[2] https://www.moh.gov.sg/resources-statistics/singapore-health-facts/principal-causes-of-death
[3] https://www.mckinsey.com/industries/healthcare/our-insights/the-next-frontier-of-care-delivery-in-healthcare
[4] https://www.moh.gov.sg/news-highlights/details/number-of-registered-day-surgery-centres-in-public-and-private-sectors-and-patient-load
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
HMI Medical Announces Partnership with Advanced Urology Associates to Expand its Specialist Service Offerings
HMI Medical Announces Partnership with Advanced Urology Associates to Expand its Specialist Service Offerings
